Tumor necrosis factor receptor 2 activation elicits sex-specific effects on cortical myelin proteins and functional recovery in a model of multiple sclerosis. Brain research bulletin, (207):110885--110885, United States, January 2024. [PUMA: 2024 izi kontermann pfizenmaier] URL
Evaluation of the Neutralizing Antibody STE90-C11 against SARS-CoV-2 Delta Infection and Its Recognition of Other Variants of Concerns. Viruses, (15)11:2153--, Switzerland, October 2023. [PUMA: 2023 izi kontermann] URL
The TNFR1 antagonist Atrosimab reduces neuronal loss, glial activation and memory deficits in an acute mouse model of neurodegeneration. Scientific reports, (13)1:10622--10622, England, June 2023. [PUMA: 2023 izi kontermann pfizenmaier] URL
Combination of a bispecific antibody and costimulatory antibody-ligand fusion proteins for targeted cancer immunotherapy. Journal of Immunotherapy, (35)5:418--429, June 2012. [PUMA: 2012 izi kontermann] URL
Alternative antibody formats.. Current opinion in molecular therapeutics, (12)2:176--183, 2010. [PUMA: 2010 izi kontermann] URL
Improved monovalent TNF receptor 1-selective inhibitor with novel heterodimerizing Fc. mAbs, 1--13, Taylor & Francis, March 2019. [PUMA: 2019 izi kontermann pfizenmaier] URL
Inhibition of tumor cell growth and cancer stem cell expansion by a bispecific antibody targeting EGFR and HER3. Mol Cancer Ther, May 2020. [PUMA: 2020 izi kontermann olayioye] URL
Antagonists of TNF action: clinical experience and new developments. Expert Opinion on Drug Discovery, (4)3:279--292, 2009. [PUMA: 2009 izi kontermann pfizenmaier] URL
Immunoliposomes for Targeted Delivery of an Antifibrotic Drug. Molecular Pharmaceutics, (12)9:3146--3157, September 2015. [PUMA: 2015 izi kontermann] URL
Astrocyte-specific activation of TNFR2 promotes oligodendrocyte maturation by secretion of leukemia inhibitory factor. Glia, (62)2:272--283, February 2014. [PUMA: 2014 izi kontermann pfizenmaier] URL
In vivo near-infrared fluorescence imaging of FAP-expressing tumors with activatable FAP-targeted, single-chain Fv-immunoliposomes. Journal of Controlled Release, (186):1--10, July 2014. [PUMA: 2014 izi kontermann] URL
Tropism Modification of Adenovirus Vectors by Peptide Ligand Insertion into Various Positions of the Adenovirus Serotype 41 Short-Fiber Knob Domain. Journal of Virology, (81)6:2688--2699, 2007. [PUMA: 2007 izi kontermann] URL
Pharmacokinetic properties of IgG and various Fc fusion proteins in mice. mAbs, (8)1:120--128, January 2016. [PUMA: 2016 izi kontermann] URL
Superior Treg-expanding properties of a novel dual-acting cytokine fusion protein. Frontiers in Pharmacology, (10):1490, Frontiers, 2019. [PUMA: 2019 fischer izi kontermann] URL
Preclinical efficacy of endoglin-targeting antibody-drug conjugates for the treatment of Ewing sarcoma. Clinical Cancer Research, clincanres.0936.2018, November 2018. [PUMA: 2018 izi kontermann] URL
Process development of periplasmatically produced single chain fragment variable against epidermal growth factor receptor in Escherichia coli. Journal of Biotechnology, (192):136--145, Elsevier BV, December 2014. [PUMA: 2014 izi kontermann] URL
An anti-TNFR1 scFv-HSA fusion protein as selective antagonist of TNF action. Protein Engineering, Design and Selection, (26)10:581--587, October 2013. [PUMA: 2013 izi kontermann pfizenmaier] URL
Generation of “LYmph Node Derived Antibody Libraries” (LYNDAL) for selecting fully human antibody fragments with therapeutic potential. mAbs, (6)1:130-142, Taylor & Francis, 2014. [PUMA: 2014 izi kontermann] URL
An optimized antibody-single-chain TRAIL fusion protein for cancer therapy. mAbs, (8)5:879--891, July 2016. [PUMA: 2016 izi kontermann pfizenmaier] URL
Humanization of a mouse monoclonal antibody directed against a cell surface-exposed epitope of membrane-associated heat shock protein 70 (Hsp70). Molecular Biotechnology, (46)3:265--278, 2010. [PUMA: 2010 izi kontermann] URL